Evolus (EOLS) Total Liabilities (2017 - 2026)
Evolus (EOLS) posted Total Liabilities of $249.4 million for Q1 2026, little changed on a QoQ basis from $249.0 million in Q4 2025, and up 13.39% year-over-year from $220.0 million in Q1 2025.
Evolus (EOLS) Total Liabilities (2017 - 2026) Analysis & Trends
Evolus' Total Liabilities history runs 10 years deep, the most recent figure standing at $249.4 million for Q1 2026.
- Quarterly Total Liabilities rose 13.39% year-over-year to $249.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $249.4 million (up 13.39% YoY) and the FY2025 annual result came in at $249.0 million, up 9.66% from the prior year.
- Total Liabilities was $249.4 million for Q1 2026 at Evolus, roughly flat from $249.0 million in the prior quarter.
- Across five years, Total Liabilities topped out at $249.4 million in Q1 2026 and bottomed at $153.3 million in Q1 2023.
- A 5-year average of $203.1 million and a median of $209.7 million in 2023 frame the typical range for Total Liabilities.
- Peak annual rise in Total Liabilities reached 38.77% in 2022, while the deepest fall reached 9.18% in 2022.
- Evolus' Total Liabilities stood at $159.5 million in 2022, then surged by 31.48% to $209.7 million in 2023, then rose by 8.28% to $227.0 million in 2024, then climbed by 9.66% to $249.0 million in 2025, then increased by 0.18% to $249.4 million in 2026.
- Business Quant data shows EOLS's Total Liabilities at $249.4 million in Q1 2026, $249.0 million in Q4 2025, and $247.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | 249.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 249.43 Mn |
| Dec 31, 2025 | 248.97 Mn |
| Sep 30, 2025 | 247.76 Mn |
| Jun 30, 2025 | 247.46 Mn |
| Mar 31, 2025 | 219.97 Mn |
| Dec 31, 2024 | 227.05 Mn |
| Sep 30, 2024 | 223.72 Mn |
| Jun 30, 2024 | 214.46 Mn |
| Mar 31, 2024 | 207.73 Mn |
| Dec 31, 2023 | 209.69 Mn |
| Sep 30, 2023 | 187.34 Mn |
| Jun 30, 2023 | 175.95 Mn |
| Mar 31, 2023 | 153.29 Mn |
| Dec 31, 2022 | 159.48 Mn |
| Sep 30, 2022 | 163.50 Mn |
| Jun 30, 2022 | 164.06 Mn |
| Mar 31, 2022 | 153.41 Mn |
| Dec 31, 2021 | 175.61 Mn |
| Sep 30, 2021 | 117.82 Mn |
| Jun 30, 2021 | 133.73 Mn |